Cited by 106Ocular Diseases and Behçet’s SyndromeOcular Oncology and TreatmentsOcular Infections and Treatments

Mycophenolate mofetil in the treatment of uveitis in children

Open access
Doycheva, D, Deuter, C, Stuebiger, N, Biester, S, Zierhut, M·2007·British Journal of Ophthalmology

Abstract

BACKGROUND: Mycophenolate mofetil (MMF) is a new immunosuppressive agent that effectively controls the intraocular inflammation in adults. PURPOSE: To assess the efficacy of MMF in uveitis in children and to analyse the possible side effects. PARTICIPANTS AND METHODS: A retrospective analysis was carried out on 17 children (32 eyes) with intraocular inflammation treated with MMF and followed up at the University Eye Hospital Tuebingen, Tuebingen, Germany, between 2000 and 2005. All children had chronic non-infectious uveitis and received MMF for at least 6 months. All patients were given steroids or other immunosuppressive agents before initiating treatment with MMF. RESULTS: 17 children (10 boys and 7 girls) with a mean age of 8 (range 2-13) years at the onset of uveitis were examined. The average duration of follow-up after initiation of MMF was 3 (range 2-5) years. A steroid-sparing effect was achieved in 88% of the patients. The oral prednisolone was successfully discontinued in 41% children and reduced to a daily dose of < or =5 mg in 47% of the children. 24% of the patients remained relapse-free during the treatment, but a reduction in the relapse rate was observed in all other patients except one. Visual acuity was increased or maintained in 13 children (76%). Mild side effects (headache, rash, gastrointestinal discomfort) occurred in 7 patients (41%) and were the cause of discontinuation of MMF in 1 patient. CONCLUSION: The results of our study are encouraging and suggest that MMF is an effective agent also in the treatment for uveitis in children, with marked steroid-sparing potential and an acceptable side effect profile.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bjo.2006.094698

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Zierhut M, Stu ¨biger N, Aboalchamat W, et al. Immunosuppressive treatment with mycophenolate mofetil in the therapy of uveitis. Ophthalmologe 2001;98:647-51.
  2. Greiner K, Varikkara M, Santiago C, et al. Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis. Ophthalmologe 2002;99:691-4.

Cited by

Sorted by citations

Authors
Doycheva, D., Deuter, C., Stuebiger, N., Biester, S., & Zierhut, M.
Affiliations
  • Universitätsklinikum Tübingen (DE)
  • University of Tübingen (DE)
Corresponding author
Zierhut, M
Venue
British Journal of Ophthalmology
Publisher
BMJ
Published
2007-02-01
Volume
91
Issue
2
Pages
180-184
ISSN
0007-1161 (ISSN-L)
OpenAlex
W2098679112
Cited by
106
References
43
Citations by year
2025: 2 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 9 · 2015: 12 · 2014: 7 · 2013: 4 · 2012: 7
FWCI
5.70
Type
journal article
Language
en
Open access
Locations
  • British Journal of Ophthalmology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
mycophenolate mofetil, pediatric uveitis, intraocular inflammation, steroid-sparing effect, immunosuppressive therapy, relapse rate, adverse drug reactions, visual acuity outcomes
MeSH terms
Adolescent, Anti-Inflammatory Agents, Child, Child, Preschool, Chronic Disease, Drug Administration Schedule, Female, Glucocorticoids, Humans, Immunosuppressive Agents, Male, Mycophenolic Acid, Prednisolone, Recurrence, Retrospective Studies, Uveitis, Visual Acuity, Treatment Outcome, Age of Onset

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review